AtriCure Stock News

Mar 16, 2020 (The Expresswire) -- Global “Electrophysiology Mapping And Ablation Devices Market” Report 2020 is a comprehensive, professional report provides...

AtriCure (NASDAQ:ATRC) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a report released on Saturday, BidAskClub reports. A number of other brokerages also r

AtriCure (NASDAQ:ATRC) and DexCom (NASDAQ:DXCM) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, ins

The Dow Jones Industrial Index fell into bear market territory Wednesday. Here's how Dayton stocks have fared.

Charles Schwab Investment Management Inc. grew its stake in shares of AtriCure Inc. (NASDAQ:ATRC) by 3.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and E

Barclays PLC lifted its position in shares of AtriCure Inc. (NASDAQ:ATRC) by 100.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commi

PNC Financial Services Group Inc. lessened its holdings in AtriCure Inc. (NASDAQ:ATRC) by 57.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Excha

Assetmark Inc. raised its stake in AtriCure Inc. (NASDAQ:ATRC) by 30.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The inst

Today's note is really a companion piece to yesterday's. Read both. The takeaway is while the market is making its slow climb up, it will retreat multiple times

BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its holdings in shares of AtriCure Inc. (NASDAQ:ATRC) by 16.1% during the fourth quarter, according to the company in its most recent filing with the Sec

AtriCure (NASDAQ:ATRC) and Sintx Technologies (NASDAQ:SINT) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their

AtriCure (NASDAQ:ATRC) was upgraded by equities researchers at ValuEngine from a “hold” rating to a “buy” rating in a note issued to investors on Tuesday, ValuEngine reports. A number of other

The stock market tumbled this week, suffering its worst loss since the 2008 financial crisis, and local stocks didn't escape the carnage.

AtriCure (NASDAQ: ATRC) has recently received a number of price target changes and ratings updates: 2/21/2020 – AtriCure was downgraded by analysts at BidaskClub from a “strong-buy” rating to a

Equities research analysts expect that AtriCure Inc. (NASDAQ:ATRC) will post ($0.37) earnings per share (EPS) for the current quarter, according to Zacks. Five analysts have issued estimates for AtriC